Krsnaa Diagnostics IPO Basis of Allotment

Krsnaa Diagnostics Limited (our "Company" or the "Issuer") was originally incorporated as ‘Krsna Diagnostics Private Limited' at Pune, Maharashtra as a private limited company under the Companies Act, 1956, pursuant to a certificate of incorporation dated December 22, 2010, issued by the Registrar of Companies, Maharashtra at Pune ("RoC"). The name of our Company was subsequently changed to 'Krsnaa Diagnostics Private Limited', pursuant to a fresh certificate of incorporation issued by the RoC on January 29, 2015. Thereafter, our Company was converted into a public limited company pursuant to a special resolution passed in the extraordinary general meeting of the Shareholders of our Company held on April 25, 2021 and consequently the name of our Company was changed to its present name pursuant to a fresh certificate of incorporation issued by the RoC on May 6, 2021. For further details relating to the changes in the name of our Company and the registered office of our Company, see "History and Certain Corporate Matters." on page 168 of the Prospectus. Corporate Identity Number: U74900PN2010PLC138068

Our Company has filed the Prospectus dated August 10, 2021 with the Registrar of Companies, (the "Prospectus") and the Equity Shares are proposed to be listed on National Stock Exchange of India Limited ("NSE") and BSE Limited ("BSE") and the trading will commence on Monday, August 16, 2021.

INITIAL PUBLIC OFFERING OF 12,731,605 EQUITY SHARES OF FACE VALUE OF Rs. 5 EACH ("EQUITY SHARES") OF OUR COMPANY FOR CASH AT A PRICE OF Rs. 954 PER EQUITY SHARE (INCLUDING A PREMIUM OF Rs. 949 PER EQUITY SHARE) ("OFFER PRICE") AGGREGATING TO Rs. 12,133.35 MILLION ("OFFER"). THE OFFER COMPRISES OF A FRESH ISSUE OF 4,206,085 EQUITY SHARES AGGREGATING TO Rs. 4,000.00 MILLION ("FRESH ISSUE") AND AN OFFER FOR SALE OF 8,525.520 EQUITY SHARES ("OFFERED SHARES") AGGREGATING TO Rs. 8,133.35 MILLION, COMPRISING 1,600,000 EQUITY SHARES AGGREGATING TO Rs. 1,526.40 MILLION BY PHI CAPITAL TRUST-PHI CAPITAL GROWTH FUND-I, ("SELLING SHAREHOLDER 1"), 3,340,713 EQUITY SHARES AGGREGATING TO Rs. 3,187.04 MILLION BY KITARA PIIN 1104 ("SELLING SHAREHOLDER 2"). 3,563,427 EQUITY SHARES AGGREGATING TO Rs. 3,399.51 MILLION BY SOMERS.ET INDUS HEALTHCARE FUND I LIMITED ("SELLING SHAREHOLDER 3") AND 21,380 EQUITY SHARES AGGREGATING TO Rs. 20.40 MILLION BY LOTUS MANAGEMENT SOLUTIONS (ACTING THROUGH MAYUR SIRDESAI) ("SELLING SHAREHOLDER 4") AND TOGETHER WITH SELLING SHAREHOLDER 1, SELLING SHAREHOLDER 2 AND SELLING SHAREHOLDER 3, THE "SELLING SHAREHOLDERS." AND SUCH OFFER, THE "OFFER FOR SALE". THE OFFER INCLUDES AN ALLOTMENT OF 135,540 EQUITY SHARES AGGREGATING TO Rs. 116.70.00 MILLION TO ELIGIBLE EMPLOYEES (THE "EMPLOYEE RESERVATION PORTION"). THE OFFER LESS THE EMPLOYEE RESERVATION PORTION IS HEREINAFTER REFERRED TO AS THE "NET OFFER". THE OFFER AND THE NET OFFER WILL CONSTITUTE 40.55% AND 40.12% OF THE POST OFFER PAID-UP EQUITY SHARE CAPITAL OF OUR COMPANY, RESPECTIVELY.

'OUR COMPANY AND THE SELLING SHAREHOLDERS, IN CONSULTATION WITH THE BRLMS, OFFERED A DISCOUNT OF Rs. 93 PER EQUITY SHARE TO ELIGIBLE EMPLOYEES BIDDING IN THE EMPLOYEE RESERVATION PORTION ("Employee Discount").

*As on the date of this advertisement.

This Offer was made through the Book Building Process, in terms of Rule 19(2)(b) of the Securities Contracts (Regulation) Rules, 1957, as amended ("SCRR") read with Regulation 31 of the SEBI (Issue of Capital and Disclosure Requirements), Regulations, 2018 as amended ("SEBI ICDR Regulations"). This Offer was made through the Book Building Process in accordance with Regulation 6(2) of the SEBI ICDR Regulations wherein, not less than 75% of the Net Offer was allocated on a proportionate basis to Qualified Institutional Buyers ("QIBs") (the 'QIB Portion'), in consultation with the BRLMs, allocated 60% of the QIB Portion to Anchor Investors on a discretionary basis ("Anchor Investor Portion") out of which one-third was reserved for domestic Mutual Funds, in accordance with the SEBI ICDR Regulations. Further, 5% of the Not QIB Portion was available for allocation on a proportionate basis to Mutual Funds only, and the remainder of the QIB Portion v/as available for allocation on a proportionate basis to all QIB Bidders (other than Anchor Investors), including Mutual Funds Further, not more than 15% of the Not Offer was available for allocation on a proportionate basis to Non-Institutional Bidders and not more than 10% of the Net Offer was available for allocation to Retail Individual Bidders ( 'RIBs') in accordance with the SEBI ICDR Regulations Further as per Prospectus. 232,288 Equity Shares aggregating to 200.00 million wore available for allocation to Eligible Employees, subject to finalization of the basis of allotment. All Bidders, other than Anchor Investors, were mandatory required to participate in the Offer through the Application Supported by Blocked Amount ("ASBA") process by providing details of their respective ASBA Account (as defined hereinafter), in which the corresponding Bid Amounts was blocked by the Self Certified Syndicate Banks ('SCSBs') or under the UPI Mechanism, as the case may be. Anchor Investors were not permitted to participate in the Anchor Investor Portion through the ASBA process. For details, see "Offer Procedure" on page 355 of the Prospectus.

The Offer received 2,701,552 applications for 455,956,560 Equity Shares (before technical rejections) resulting in 35.79 times subscription. The details of the applications received in the Offer from various categories are as under:

Final Demand

A summary of the final demand as at different Bid prices is as under:

The Basis of Allotment was finalized In consultation with the Designated Stock Exchange, being the NSE on August 11, 2021.

A. Allotment to Retail Individual Bidders(After banking and after technical rejections)

The Basis of Allotment to the Retail Individual Bidders who have bid at the Cut-Off Price or at the Offer Price of Rs. 954 per Equity Share, v/as finalized in consultation with NSE. This category has been subscribed to the extent of 36.89553 times. The total number of Equity Shares Allotted m Retail Portion is 1.259.605 Equity Shares to 83.973 successful Retail Individual Bidders The category-wise details of the Basis of Allotment are as under:

Please Note; 1 additional Share shall be allotted to 10 Allottees from amongst 5,232 Successful Applicants from the categories 30-195 (i.e. excluding successful applicants from Category 15) in the ratio of 5:2616

Includes 8,731 Equity Shares spilled over from Employee Reservation Portion and added in the Retail Portion

B. Allotment to Non-Institutional Bidders(After banking and after technical rejections)

The Basis of Allotment to the Non-Institutional Bidders who have bid at the Offer Price of Rs. 954 per Equity Share or above, was finalized in consultation with NSE. The Non-Institutional Portion has been subscribed to the extent of 113 .67601 times The total number of Equity Shares Allotted in this category is 1,889.409 Equity Shares to 2.818 successful Non-Institutional Bidder. The category-wise details of the Basis of Allotment are as under (Sample)

Includes 13.097 Equity Shares spilled over from Employee Reservation Portion and added in the Non-Institutional Portion.

C. Allotment to Eligible Employees in Employee Reservation Portion (After banking and after technical rejections)

The Basis of Allotment to the Eligible Employees in the Employee Reservation Portion, who have bid at the Offer Price of Rs. 861 per Equity Share or above, was finalized in consultation with NSE. This category has been subscribed to the extent of 0.58350 times. The total number of Equity Shares allotted in this category is 135,540 Equity Shares to 353 successful applicants. The category-wise details of the Basis of Allotment areas under:

The Employee Reservation was for Rs. 200 million as mentioned in the Prospectus representing 232,288 Equity Shares at the price of Rs. 861 per Equity Share net of Employee Discount. The Un-subscribed portion of Rs. 83.30 million representing around 96,748 Equity Shares as Rs. 861 per Equity Share, translating to around 87.317 Equity shares at the Offer Price of 1954 per Equity Share has been spilled over to QIB Portion. Non- Institutional Portion and Retail Portion in the ratio of 75:15:10. The balance 9,431 Equity Shares cannot be allocated to any category, since the Fresh Issue is aggregating to f 4,000 million.

D. Allotment to QIBs (Excluding Anchor Investors)

Allotment to QIBs. who have Bid at the Offer Price of Rs. 954 per Equity Share, has been done on a proportionate basis in consultation with NSE. This category has been subscribed to the extent of 4886568 times of QIB Portion. As per the SEBIICDR Regulations. Mutual Funds were Allotted 5% of the Equity Shares of QIB Portion available i.e. 190,906 Equity Shares. The remaining available Equity Shares i.e. 3,627,208 Equity Shares were Allotted on a proportionate basis to Mutual Funds and Other QlBs. The total number of Equity Shares Allotted in the QlB Portion is 3,818,114 Equity Shares, which were allotted to 128 successful QIB Bidders The category-wise details of the Basis of Allotment are as under:

Includes 65,489 Equity Shares spilled over from Employee Reservation Portion and added in the QIB Portion,

E. Allotment to Anchor Investors

The bidding for Anchor Investor opened and closed on August 3, 2021. The company received 44 applications from 32 anchor Investors for 6,257,865 equity shares. The Anchor Investor Price was finalized at Rs. 954 per Equity Share A total of 5.628.937 shares were allocated under the Anchor Investor Portion aggregating to 5,370,005,898/-

In terms of Prospectus dated August 10, 2021 and Basis of Allotment post taking into account spill over from Employee Reservation Portion, the final Offer Structure is as follows:

^ Net of Employee Discount. The entire Employee Reservation Portion is from the Fresh Issue.

The IPO Committee of our Company on August 11, 2021 has taken on record the Basis of Allotment of Equity Shares approved by the Designated Stock Exchange, being NSE and has allotted the Equity Shares to various successful Bidders. The Allotment Advice-cum- Intimations and/ or notices will be dispatched via email / post at the address of the Investors as registered with the depositories. Further, the instructions to the Self Certified Syndicate Banks for unblocking of funds, transfer to Public Offer Account have been issued on August 11, 2021 and payment to non-Syndicate brokers have been issued on August 12, 2021 In case the same is not received within ten days, Investors may contact the Registrar to the Offer at the address given below. The Equity Shares Allotted to the successful Allottees have been uploaded on August 12, 2021 for credit into the respective beneficiary accounts subject to validation of the account details with the depositories concerned. The Company has filed the Listing application with NSE and BSE on August 12, 2021. The Company has received listing and trading approval from NSE and BSE and the trading will commence on August 16, 2021.

All capitalised terms used and not specifically defined herein shall have the same meaning as ascribed to them in the Prospectus dated August 10, 2021 and filed with RoC on August 10, 2021 and thereafter with SEBI and the Stock Exchanges. Percentage figures have been rounded off to two decimal places,

INVESTORS PLEASE NOTE

The details of the allotment made will be hosted on the website of the Registrar to the Offer, KFin Technologies Private Limited at www.kfintech.com

All future correspondence in this regard may kindly be addressed to the Registrar to the Offer quoting full name of the first/sole Bidder. Bid cum Application Form number. Bidder DP ID, Client ID, PAN, date of submission of Bid cum Application Form, address of the Bidder, number of Equity Shares applied for the name and address of the Designated Intermediary v/here the Bid cum Application Form was submitted by the Bidder and a copy of the Acknowledgment Slip received from the Designated Intermediary at the address given below.

	KFin Technologies Private Limited
	Selenium Tower B, Plot 31 & 32, Gachibowti, Financial District,
	Nanakramguda, Serilingampally, Hyderabad - 500 032, Telangana
	Telephone +91 40 6716 2222; Email: krsnaa.ipo@kfintech.com
	Website; www.kfintech.com; Investor grievance e-mail: einward.ris@kfintech.com
	Contact person M. Murali Krishna; SEBI registration no.: INR000000221

THE LEVEL OF SUBSCRIPTION SHOULD NOT BE TAKEN TO BE INDICATIVE OF EITHER THE MARKET PRICE OF THE EQUITY SHARES ON LISTING OR THE BUSINESS PROSPECTS OF KRS.NAA DIAGNOSTICS LIMITED.

Krsnaa Diagnostics Limited has filed the Prospectus dated August 10, 2021 with RoC and thereafter with SEBI and the Stock Exchanges. The Prospectus shall be available on the website of SEBI at www.sebi.gov.in, websites of the Stock Exchanges i.e. NSE and BSE at www.nseindia.com and www.bseindia.com, respectively, and is available on the websites of the BRLMs i.e. JM Financial Limited DAM Capital Advisors Limited (Formerly IDFC Securities Limited), Equirus Capital Private Limited and IIFL Securities Limited at www.jmfl.com, www.damcapital.in, www.equirus.com, and www.iiflcap.com, respectively. Bidders should note that Investment in equity shares involves a high degree of risk and for details refer to the Prospectus, including the section titled 'Risk Factors' on page 24 of the Prospectus.

The Equity Shares offered in the Offer have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act'') or any other applicable law of the United States and, unless so registered, may not be offered or sold within the United States, except pursuant to an exemption from, or in a transaction not subject to the registration requirements of the Securities Act and applicable state securities laws. Accordingly, the Equity Shares are only being offered and sold (i) within the United States only to persons reasonably believed to be "qualified Institutional buyers" (as defined in Rule 144A under the Securities Act. ("Rule 144 A") in transactions exempt from, or not subject to, registration requirements of the Securities Act. and (ii) outside the United States in offshore transactions in reliance on Regulations under the Securities Act and pursuant to the applicable laws of the jurisdictions where those offers and sales are made There will be no public offering of the Equity Shares in the United States.